Redwood Wealth Management Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Redwood Wealth Management Group's BMY Position: Q2 2026 in Review
Redwood Wealth Management Group sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 14,456 shares — an estimated $877K sold.
Redwood Wealth Management Group first reported a position in BMY in Q4 2022 and held it in 14 quarters. The position peaked at $877K in Q1 2026. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Redwood Wealth Management Group reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
- Redwood Wealth Management Group sold 14,456 Bristol-Myers Squibb shares in Q2 2026, an estimated $877K.
- Redwood Wealth Management Group first reported a position in Bristol-Myers Squibb in Q4 2022 and held it in 14 quarters.
- Redwood Wealth Management Group's Bristol-Myers Squibb position peaked at $877K in Q1 2026.
- 2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Redwood Wealth Management Group's 13F filing for Q2 2026.